Tag: Medicare Part D
How the US Government Regulates Generic Drug Prices
The US government regulates generic drug prices through programs like Medicaid rebates and Medicare Part D. Learn how these policies affect costs, patient affordability, and recent changes under the Inflation Reduction Act. Key mechanisms include the Medicaid Drug Rebate Program and the 340B initiative, which lower prices for vulnerable populations. Current debates focus on price volatility and international comparisons. Discover how these regulations impact everyday healthcare costs.
Out-of-Pocket Costs: What Patients Really Pay for Generic vs Brand-Name Drugs
Generic drugs are cheaper - but not always for you. Learn why out-of-pocket costs for generics can be higher than brand-name drugs, how Medicare Part D tricks patients, and how to pay less using cash and transparency tools.
-
27.01.26 -
Alistair Mukondiwa -
14
- Drug Information (71)
- Health and Wellness (59)
- Pharmacy Information (25)
- Medical Conditions (24)
- Supplements (4)
- Diabetes (4)
- Travel Health (3)
- Mental Health (3)
- Heart Health (2)
- Parenting (2)
-
Patient Communication During Drug Shortages: What Providers Must Do
20 Jan 2026 -
Cephalexin vs Other Antibiotics: Complete Comparison of Cephadex and Alternatives
26 Oct 2025 -
Pregnancy Registries: What We’re Learning About Medication Safety
17 Nov 2025 -
MAO Inhibitors: Dangerous Interactions with Common Medications
14 Nov 2025 -
Entocort (budesonide): Uses, Dosage, Side Effects, and Alternatives in 2025
27 Aug 2025
4.02.26
Alistair Mukondiwa
12